Fate Therapeutics Stock (NASDAQ: FATE) stock price, news, charts, stock research, profile.
Open | $3.90 |
Close | - |
Volume / Avg. | 35.64K / 1.79M |
Day Range | $3.77 - $3.90 |
52 Wk Range | 1.63 - 8.83 |
Market Cap | $431.60M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 15.29% |
Days to Cover | 11.29 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Fate Therapeutics (NASDAQ:FATE) through any online brokerage.
Other companies in Fate Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Inozyme Pharma (NASDAQ:INZY), Larimar Therapeutics (NASDAQ:LRMR) and Sage Therapeutics (NASDAQ:SAGE).
Fate Therapeutics has a consensus price target of $8.05.
The stock price for Fate Therapeutics (NASDAQ: FATE) is $3.79 last updated September 23, 2024 at 9:55 AM EDT.
There are no upcoming dividends for Fate Therapeutics.
Fate Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Fate Therapeutics.
Fate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.